The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Sweet's Syndrome

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Sweet's Syndrome


High impact information on Sweet's Syndrome


Chemical compound and disease context of Sweet's Syndrome


Biological context of Sweet's Syndrome

  • The clinicopathologic manifestations of Sweet's syndrome associated with hematologic disorders (HSS) were more severe and characterized by bullous pyoderma with more pronounced epidermal changes and ulceration, anemia, giant platelets and abnormal platelet counts [13].

Anatomical context of Sweet's Syndrome


Gene context of Sweet's Syndrome


Analytical, diagnostic and therapeutic context of Sweet's Syndrome


  1. Sweet's syndrome associated with rheumatoid arthritis. Harary, A.M. Arch. Intern. Med. (1983) [Pubmed]
  2. Sweet's syndrome involoving the musculoskeletal system during treatment of promyelocytic leukemia with all-trans retinoic acid. Christ, E., Linka, A., Jacky, E., Speich, R., Marincek, B., Schaffner, A. Leukemia (1996) [Pubmed]
  3. Treatment of Sweet's syndrome (active febrile neutrophilic dermatosis) with indomethacin. Hoffman, G.S. J. Rheumatol. (1977) [Pubmed]
  4. Hydralazine induced lupus and Sweet's syndrome. Juanola, X., Nolla, J.M., Servitje, O., Valverde, J. J. Rheumatol. (1991) [Pubmed]
  5. Antineutrophil cytoplasmic antibodies of IgA class in neutrophilic dermatoses with emphasis on erythema elevatum diutinum. Ayoub, N., Charuel, J.L., Diemert, M.C., Barete, S., André, M., Fermand, J.P., Piette, J.C., Francès, C. Archives of dermatology. (2004) [Pubmed]
  6. The Sweet syndrome or G-CSF reaction? Karp, D.L. Ann. Intern. Med. (1992) [Pubmed]
  7. Malignancy-associated Sweet's syndrome: review of the world literature. Cohen, P.R., Talpaz, M., Kurzrock, R. J. Clin. Oncol. (1988) [Pubmed]
  8. Neutrophil-poor Sweet's syndrome with response to potassium iodide. Smith, H.R., Ashton, R.E., Beer, T.W., Theaker, J.M. Br. J. Dermatol. (1998) [Pubmed]
  9. Indomethacin treatment of eighteen patients with Sweet's syndrome. Jeanfils, S., Joly, P., Young, P., Le Corvaisier-Pieto, C., Thomine, E., Lauret, P. J. Am. Acad. Dermatol. (1997) [Pubmed]
  10. Minocycline-induced Sweet's syndrome. Thibault, M.J., Billick, R.C., Srolovitz, H. J. Am. Acad. Dermatol. (1992) [Pubmed]
  11. Acute febrile neutrophilic dermatosis (Sweet's syndrome). Response to dapsone. Aram, H. Archives of dermatology. (1984) [Pubmed]
  12. Postpolycythemic myeloid metaplasia, Sweet's syndrome, and acute myeloid leukemia. Horan, M.P., Redmond, J., Gehle, D., Dabe, I.B., Fort, S.L. J. Am. Acad. Dermatol. (1987) [Pubmed]
  13. Sweet's syndrome: clinicopathologic study of eleven cases. Chan, H.L., Lee, Y.S., Kuo, T.T. International journal of dermatology. (1994) [Pubmed]
  14. HLA-DR expression on keratinocytes is a common feature of diseased skin. Auböck, J., Romani, N., Grubauer, G., Fritsch, P. Br. J. Dermatol. (1986) [Pubmed]
  15. Hyperfunction of neutrophils in a patient with BCR/ABL negative chronic myeloid leukemia: a case report with in vitro studies. Watari, K., Tojo, A., Nagamura-Inoue, T., Matsuoka, M., Irie, S., Tani, K., Yamada, Y., Asano, S. Cancer (2000) [Pubmed]
  16. An immunohistochemical study of the dermal infiltrate and epidermal staining for interleukin 1 in 12 cases of Sweet's syndrome. Bourke, J.F., Jones, J.L., Fletcher, A., Graham-Brown, R.A. Br. J. Dermatol. (1996) [Pubmed]
  17. Sweet's syndrome associated with sargramostim (granulocyte-macrophage colony stimulating factor) treatment. Kumar, G., Bernstein, J.M., Waibel, J.S., Baumann, M.A. Am. J. Hematol. (2004) [Pubmed]
  18. Treatment of recurrent Sweet's syndrome with coexisting rheumatoid arthritis with the tumor necrosis factor antagonist etanercept. Yamauchi, P.S., Turner, L., Lowe, N.J., Gindi, V., Jackson, J.M. J. Am. Acad. Dermatol. (2006) [Pubmed]
  19. Sweet's syndrome associated with polycythemia rubra vera. Cox, N.H., Leggat, H. J. Am. Acad. Dermatol. (1990) [Pubmed]
  20. Sweet syndrome in patients with solid tumors. Cohen, P.R., Holder, W.R., Tucker, S.B., Kono, S., Kurzrock, R. Cancer (1993) [Pubmed]
  21. Sweet's syndrome: a review of current treatment options. Cohen, P.R., Kurzrock, R. American journal of clinical dermatology. (2002) [Pubmed]
WikiGenes - Universities